Investors & Media

Company Profile

Business Description

Sangamo Therapeutics is a genomic medicine company focused on leveraging our novel platforms and scientific expertise to advance programs into the clinic. Our platforms have yielded multiple clinical stage programs that could provide value in the near-to-mid-term. We have a robust preclinical pipeline with programs in emerging areas that could provide value in the mid-to-long term.

Our goal is to operate a wholly owned genomic medicine pipeline, which we fund via our collaborations with blue chip pharma partners, which have already brought in $815M in upfronts and milestones with $7B in potential bio bucks. We believe that manufacturing is a strategic advantage and gives us greater control over timelines, quality and supply. Our strong balance sheet enables us to execute and deliver on our mission.

Headquarters

7000 Marina Blvd, Brisbane, CA 94005

ir overview


Industry Classifications

Sector
Healthcare
Industry
Biotechnology
NAICS
Biological Product (Except Diagnostic) Manufacturing (325414)
SIC
Biological Products, Except Diagnostic Substances (2836)

Stock Information
Change
Volume
Today's Open
Previous Close
Today's High
Today's Low
52 Week High
52 Week Low
Stock Chart

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Historical Lookup

Week of September 20, 2021

Date Requested Closing Price Volume Split Adjustment Factor Open Price Day High Day Low
September 20, 2021 $9.28 914,663 1:1 $9.28 $9.50 $9.15
September 21, 2021 $9.54 873,355 1:1 $9.34 $9.61 $9.31
September 22, 2021 $9.60 713,254 1:1 $9.62 $9.66 $9.46
September 23, 2021 $9.83 725,212 1:1 $9.62 $9.83 $9.51
September 24, 2021 $9.60 676,611 1:1 $9.70 $9.81 $9.54

Contacts